Public affairs campaign in hostile ecosystem (environment) about the price question
For American company (Q2-Q3-Q4 2016)
Objective
Standing an American pharmaceutical company as a public health player, leader in cancer innovation
Opening the thought about the management of oncology patients care
Developing a positive environment to the market access for their product
Approach and methodology
Smoothen relations between the public authority and the pharmaceutical laboratories about the price question of the innovative products
Coordination of the round tables over 10 players (health professionals, patients, institutions)
Organization of conferences
Client outcomes
A significant gain of awareness among the institutional players and public authorities
The first pharmaceutical laboratory to get out the negotiation on this category of products
White paper with the view of the stakeholders
THIS BUSINESS CASE INTERESTS YOU? CONTACT MICKAEL HALIMI :
Mickael Halimi
Public Affairs Manager
Tel: 01 53 38 48 67
[caldera_form id=”CF5bcdec1c4980a”]
Objective
Standing an American pharmaceutical company as a public health player, leader in cancer innovation
Opening the thought about the management of oncology patients care
Developing a positive environment to the market access for their product
Approach and methodology
Smoothen relations between the public authority and the pharmaceutical laboratories about the price question of the innovative products
Coordination of the round tables over 10 players (health professionals, patients, institutions)
Organization of conferences
Client outcomes
A significant gain of awareness among the institutional players and public authorities
The first pharmaceutical laboratory to get out the negotiation on this category of products
White paper with the view of the stakeholders
THIS BUSINESS CASE INTERESTS YOU? CONTACT MICKAEL HALIMI :
Mickael Halimi
Public Affairs Manager
Tel: 01 53 38 48 67
[caldera_form id=”CF5bcdec1c4980a”]
